LORI BROWN-HALBERT: Open Payments
NPI 1669466389 · POUGHKEEPSIE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,443 in 87 payments from 17 companies in 2025. Trend: 2023 $1,467 · 2024 $1,368 · 2025 $2,443
Food & beverage: $2,443
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $613 |
| Madrigal Pharmaceuticals | 11 | $349 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $275 |
| Janssen Biotech, Inc. | 3 | $181 |
| QOL Medical, LLC | 3 | $177 |
| Regeneron Healthcare Solutions, Inc. | 4 | $164 |
| Aimmune Therapeutics, Inc. | 1 | $113 |
| Lilly USA, LLC | 4 | $106 |
| Ardelyx, Inc. | 4 | $89 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $82 |
Products named: RINVOQ, REZDIFFRA, XIFAXAN, DUPIXENT, TREMFYA, Sucraid, SKYRIZI, ZENPEP.
Industry payments across NY — which companies pay providers there.
